Month: March 2015

Many of you may be familiar with ProAir HFA, one of three brand-only albuterol inhalers currently available. Now, the FDA has tentatively approved a new dry powder inhaler from TEVA pharmaceuticals that will be known as the ProAir Respiclick. When the pharmaceutical company first filed their new drug application (NDA) for the medication, in July of… Read More

On February 25, 2015, the FDA approved Toujeo—a long-acting insulin indicated to improve sugar control in adults with type 1 and type 2 diabetes. When will Toujeo be available? According to the manufacturer, Sanofi-Aventis, Toujeo will be available at the beginning of the second quarter in 2015. What is long-acting insulin? Long-acting insulin can also be… Read More

Photoaging. That’s the term for skin changes that occur with sun and age. You know this as the fine and coarse wrinkles, brown spots, mottled pigmentation, loss of elasticity, and sallow color that happens as we get older. Sun protection is the best way to prevent or improve photoaging, but other things also work. Many… Read More

When you pick up your medications at the pharmacy you may notice that they are typically dispensed in amber colored vials or plastic containers. You may or may not be aware that these amber colored vials are not the original bottle the manufacturer dispensed the medication in. For the majority of medications, transferring them from… Read More

When you think of conditions where an over-the-counter medication will help, lowering your cholesterol may not be the first thing that comes to mind. Most people think of OTC medications for minor problems like cough and cold, allergies, upset stomach, and mild aches and pains. It may seem strange that there are medications available over the counter… Read More

Onychomycosis is a fungal infection of the nail and the most common nail disorder. It is more common as we get older and with factors like diabetes, sweating, sports activities, occlusive footwear, and repeated nail trauma. Topical treatments eliminate the need for surveillance blood tests and cause less systemic complications. Two new nail solutions were… Read More

On March 6, 2015, the FDA approved the first biosimilar for distribution in the United States. This is a huge approval, and an accomplishment for the pharmaceutical company, Sandoz, and their biosimilar, Zarxio (filgrastim-sndz). This is such important news because biosimilars like Zarxio will offer a reduced cost alternative therapy to their expensive biologic counterparts… Read More

Breo Ellipta (fluticasone furoate and vilanterol), an inhalation powder used for the treatment of COPD, was the first Ellipta inhaler to become available back in 2013. Over the past two years or so, several more Ellipta options have entered the market. Ellipta medications tend to be a bit more expensive, but some people prefer them… Read More

Spiriva (tiotropium bromide) is now available as a Respimat inhaler in addition to the original Handihaler formulation. Although this may come as a surprise—why would we need a new version of Spiriva?—it is not the first time we have seen something like this from the pharmaceutical manufacturer Boehringer Ingelheim. For example, before the original Combivent… Read More

a doctor's prescription pad

Post-nasal drip has a new name: upper airway cough syndrome  or UACS. If you have a cough that won’t go away, along with nasal congestion, “dripping” mucus down the back of your throat, the sensation that you need to clear your throat, a hoarse voice, or if you wake up in the morning with “gunk”… Read More